SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Laurus Labs invests Rs 39.99 crore in Laurus Bio

26 Jun 2025 Evaluate

Laurus Labs has invested Rs 39.99 crore in its subsidiary -- Laurus Bio through acquisition of 15,414 Series A2 Compulsorily Convertible Preference Shares of Laurus Bio at face value of Rs 100 and premium of Rs 25,850.02 by way of Private Placement cum Preferential Allotment basis.

Earlier, company’s board had approved the approved for investment of an amount Rs 40 crore in Laurus Bio. 

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

1135.00 5.40 (0.48%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×